Table of Content


1 INTRODUCTION (Page No. - 41)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           FIGURE 1 MARKET SEGMENTATION
           1.3.1 REGIONS COVERED
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
           TABLE 1 USD EXCHANGE RATES, 2020–2023
    1.6 UNIT CONSIDERED 
    1.7 STAKEHOLDERS 
2 RESEARCH METHODOLOGY (Page No. - 45)
    2.1 RESEARCH DATA 
           FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
    2.2 FACTOR ANALYSIS 
           2.2.1 INTRODUCTION
           2.2.2 DEMAND-SIDE ANALYSIS
                    FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020–2023 (USD BILLION)
           2.2.3 SUPPLY-SIDE ANALYSIS
                    FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
    2.3 MARKET SIZE ESTIMATION 
           2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
           2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET)
    2.4 DATA TRIANGULATION 
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 LIMITATIONS & RISK ASSESSMENT 
    2.7 RECESSION IMPACT ANALYSIS 
           2.7.1 MACRO-INDICATORS OF RECESSION
                    FIGURE 7 RECESSION INDICATORS
                    FIGURE 8 GLOBAL INFLATION RATE, 2013–2023
                    FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013–2023 (USD TRILLION)
                    FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
                    FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY (Page No. - 61)
    TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029 
    FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 
    FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 
    FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 
    FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT 
4 PREMIUM INSIGHTS (Page No. - 66)
    4.1 OPPORTUNITIES FOR PLAYERS IN SPECIALTY ENZYMES MARKET 
           FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES
    4.2 SPECIALTY ENZYMES MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS 
           FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023
    4.3 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE & KEY COUNTRY 
           FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
    4.4 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE 
           FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION 
           FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 69)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 INCREASE IN RETAIL SALES
                    FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018–2023 (USD BILLION)
           5.2.2 GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA
                    FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022
    5.3 MARKET DYNAMICS 
           FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.3.1 DRIVERS
                    5.3.1.1 Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics
                    5.3.1.2 Supportive government policies and funding
                    5.3.1.3 Advanced tools to optimize pharmaceutical production
                               FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000–2022 (USD MILLION)
           5.3.2 RESTRAINTS
                    5.3.2.1 Lack of harmonization in regulatory framework
                    5.3.2.2 High costs associated with specialty enzymes
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Rising significance of catalysts in pharmaceutical industry
                    5.3.3.2 Technological innovations and wide industry scope
                               FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017–2023 (USD BILLION)
                    5.3.3.3 Development of enzymes with long shelf life
                    5.3.3.4 Need for encapsulation to enhance shelf life of enzymes
                    5.3.3.5 Utilization of plant biomass for production of specialty enzymes
           5.3.4 CHALLENGES
                    5.3.4.1 High research and development costs
                    5.3.4.2 Competition from alternative technologies or products
6 INDUSTRY TRENDS (Page No. - 80)
    6.1 INTRODUCTION 
    6.2 SUPPLY CHAIN ANALYSIS 
           FIGURE 26 SUPPLY CHAIN ANALYSIS
    6.3 VALUE CHAIN ANALYSIS 
           FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS
    6.4 TRADE ANALYSIS 
           6.4.1 EXPORT SCENARIO OF SPECIALTY ENZYMES
                    FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
                    TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
           6.4.2 IMPORT SCENARIO OF SPECIALTY ENZYMES
                    FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
                    TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
    6.5 TECHNOLOGY ANALYSIS 
           6.5.1 KEY TECHNOLOGIES
                    6.5.1.1 Protein engineering for drug delivery
                    6.5.1.2 Next-Generation Sequencing (NGS) for enzyme-based diagnostics
                    6.5.1.3 Directed evolution of enzymes
           6.5.2 ADJACENT TECHNOLOGIES
                    6.5.2.1 Food enzymes immobilization
    6.6 PRICING ANALYSIS 
           6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
                    FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022–2023 (USD/KG)
                    TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020–2023 (USD/KG)
           6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
                    FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
                    TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
    6.7 ECOSYSTEM 
           6.7.1 SUPPLY SIDE
           6.7.2 DEMAND SIDE
                    FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM
                    TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM
    6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    6.9 PATENT ANALYSIS 
           FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
           TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020–2024
    6.1 KEY CONFERENCES & EVENTS, 2024–2025 
           TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024–2025
    6.11 REGULATORY LANDSCAPE 
           6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.11.2 REGULATIONS, BY REGION
                    6.11.2.1 North America
                               6.11.2.1.1 US
                               6.11.2.1.2 Canada
                    6.11.2.2 Europe
                               6.11.2.2.1 European Union
                    6.11.2.3 Asia Pacific
                               6.11.2.3.1 China
                               6.11.2.3.2 India
                    6.11.2.4 South America
                               6.11.2.4.1 Brazil
    6.12 PORTER’S FIVE FORCES ANALYSIS 
                    TABLE 14 SPECIALTY ENZYMES MARKET: PORTER’S FIVE FORCES ANALYSIS
           6.12.1 INTENSITY OF COMPETITIVE RIVALRY
           6.12.2 BARGAINING POWER OF SUPPLIERS
           6.12.3 BARGAINING POWER OF BUYERS
           6.12.4 THREAT OF SUBSTITUTES
           6.12.5 THREAT OF NEW ENTRANTS
    6.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
                    TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
           6.13.2 BUYING CRITERIA
                    TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
                    FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
    6.14 CASE STUDIES 
           6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
           6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
           6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
    6.15 INVESTMENT AND FUNDING SCENARIO 
                    FIGURE 37 INVESTMENT AND FUNDING SCENARIO
7 SPECIALTY ENZYMES MARKET, BY TYPE (Page No. - 103)
    7.1 INTRODUCTION 
           FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
           TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
           TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
           TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (KILOTONS)
           TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (KILOTONS)
    7.2 CARBOHYDRASES 
           7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
                    TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                    TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                    TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
           7.2.2 AMYLASES
                    TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
           7.2.3 CELLULASES
                    TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
           7.2.4 OTHER CARBOHYDRASES
                    TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
    7.3 PROTEASES 
           7.3.1 INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET
                    TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
    7.4 LIPASES 
           7.4.1 USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET
                    TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
    7.5 POLYMERASES & NUCLEASES 
           7.5.1 PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH
                    TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                    TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
    7.6 OTHER ENZYMES 
           TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS
           TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
           TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
           TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
           TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
8 SPECIALTY ENZYMES MARKET, BY FORM (Page No. - 120)
    8.1 INTRODUCTION 
    8.2 LIQUID 
           8.2.1 NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES
    8.3 DRY 
           8.3.1 ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH
                    FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES
9 SPECIALTY ENZYMES MARKET, BY SOURCE (Page No. - 122)
    9.1 INTRODUCTION 
           FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029
           TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
           TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
    9.2 MICROORGANISMS 
           9.2.1 NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET
                    TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.3 PLANTS 
           9.3.1 ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT
                    TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.4 ANIMALS 
           9.4.1 ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES
                    TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
10 SPECIALTY ENZYMES MARKET, BY APPLICATION (Page No. - 129)
     10.1 INTRODUCTION 
               FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029
               TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
               TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
     10.2 PHARMACEUTICALS 
             10.2.1 INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET
                       TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                       TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     10.3 RESEARCH & BIOTECHNOLOGY 
             10.3.1 DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET
                       TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                       TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     10.4 DIAGNOSTICS 
             10.4.1 SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH
                       TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                       TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     10.5 BIOCATALYSTS 
             10.5.1 BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES
                       TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
                       TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11 SPECIALTY ENZYMES MARKET, BY REGION (Page No. - 141)
     11.1 INTRODUCTION 
               FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
               TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
               TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
               TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (KILOTONS)
               TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (KILOTONS)
     11.2 NORTH AMERICA 
               FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT
             11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
                       FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2022
                       FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
                       TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                       TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                       TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
                       TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             11.2.2 US
                       11.2.2.1 Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market
                                   TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.2.3 CANADA
                       11.2.3.1 Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics
                                   TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.2.4 MEXICO
                       11.2.4.1 Need for detecting changes in substrate concentrations to boost market growth
                                   TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
                       FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2022
                       FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
                       TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                       TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                       TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
                       TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             11.3.2 ITALY
                       11.3.2.1 Rise in production of pharmaceuticals to drive demand for specialty enzymes
                                   TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.3 GERMANY
                       11.3.3.1 Rapid technological advancements in pharmaceuticals sector to boost growth
                                   TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.4 FRANCE
                       11.3.4.1 Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes
                                   TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.5 SPAIN
                       11.3.5.1 Spanish government’s emphasis on developments in pharmaceutical industry to boost enzymes market
                                   TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.6 UK
                       11.3.6.1 Increased use of enzymes in drug cloning technique to spur demand
                                   TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.7 DENMARK
                       11.3.7.1 Growing export of enzymes to propel demand for specialty enzymes
                                   TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.8 NETHERLANDS
                       11.3.8.1 Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes
                                   TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.3.9 REST OF EUROPE
                       TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     11.4 ASIA PACIFIC 
               FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT
             11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
                       FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2022
                       FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
                       TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                       TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                       TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
                       TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             11.4.2 CHINA
                       11.4.2.1 Rapid technical advancements to augment demand for specialty enzymes
                                   TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.4.3 INDIA
                       11.4.3.1 Rising demand for specialty enzymes in pharmaceutical industry to boost market
                                   TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.4.4 JAPAN
                       11.4.4.1 Growing biotechnology advancements in Japan to augment demand for specialty enzymes
                                   TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.4.5 SOUTH KOREA
                       11.4.5.1 Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes
                                   TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.4.6 AUSTRALIA & NEW ZEALAND
                       11.4.6.1 Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes
                                   TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                       TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     11.5 SOUTH AMERICA 
             11.5.1 SOUTH AMERICA: RECESSION IMPACT
                       FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018–2022
                       FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
                       TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                       TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                       TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
                       TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             11.5.2 BRAZIL
                       11.5.2.1 Thriving pharmaceutical industry to drive demand for enzymes
                                   TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.5.3 ARGENTINA
                       11.5.3.1 Government support in pharmaceuticals and research and development to boost growth
                                   TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.5.4 REST OF SOUTH AMERICA
                       TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
     11.6 REST OF THE WORLD 
             11.6.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS
                       FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017–2022
                       FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
                       TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                       TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
                       TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
                       TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
                       TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                       TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             11.6.2 AFRICA
                       11.6.2.1 Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry
                                   TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
             11.6.3 MIDDLE EAST
                       11.6.3.1 Government initiatives to promote biotechnological research and development to drive demand
                                   TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
                                   TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
                                   TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 209)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
               TABLE 218 OVERVIEW OF STRATEGIES ADOPTED BY KEY SPECIALTY ENZYME VENDORS
     12.3 REVENUE ANALYSIS 
               FIGURE 55 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD MILLION)
     12.4 MARKET SHARE ANALYSIS, 2023 
               FIGURE 56 SPECIALTY ENZYMES MARKET: DEGREE OF COMPETITION (CONSOLIDATED)
     12.5 COMPANY VALUATION AND FINANCIAL METRICS 
               FIGURE 57 SPECIALTY ENZYMES MARKET: COMPANY VALUATION (USD BILLION)
               FIGURE 58 EV/EBITDA OF KEY PLAYERS, 2023
     12.6 BRAND/PRODUCT COMPARISON 
               FIGURE 59 SPECIALTY ENZYMES MARKET: BRAND/PRODUCT COMPARISON
     12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.7.1 STARS
             12.7.2 EMERGING LEADERS
             12.7.3 PERVASIVE PLAYERS
             12.7.4 PARTICIPANTS
                       FIGURE 60 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                       FIGURE 61 SPECIALTY ENZYMES MARKET: COMPANY FOOTPRINT
                       TABLE 219 SPECIALTY ENZYMES MARKET: REGIONAL FOOTPRINT
                       TABLE 220 SPECIALTY ENZYMES MARKET: TYPE FOOTPRINT
                       TABLE 221 SPECIALTY ENZYMES MARKET: APPLICATION FOOTPRINT
     12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             12.8.1 PROGRESSIVE COMPANIES
             12.8.2 RESPONSIVE COMPANIES
             12.8.3 DYNAMIC COMPANIES
             12.8.4 STARTING BLOCKS
                       FIGURE 62 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                       12.8.5.1 Detailed list of key startups/SMEs
                                   TABLE 222 SPECIALTY ENZYMES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                       12.8.5.2 Competitive benchmarking of key startups/SMEs
                                   TABLE 223 SPECIALTY ENZYMES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 PRODUCT LAUNCHES
                       TABLE 224 SPECIALTY ENZYMES MARKET: PRODUCT LAUNCHES, DECEMBER 2021–FEBRUARY 2024
             12.9.2 DEALS
                       TABLE 225 SPECIALTY ENZYMES MARKET: DEALS, FEBRUARY 2019–APRIL 2024
             12.9.3 OTHERS
                       TABLE 226 SPECIALTY ENZYMES MARKET: OTHERS, MAY 2019–APRIL 2024
13 COMPANY PROFILES (Page No. - 234)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     13.1 KEY PLAYERS 
             13.1.1 BRAIN BIOTECH AG
                       TABLE 227 BRAIN BIOTECH AG: BUSINESS OVERVIEW
                       FIGURE 63 BRAIN BIOTECH AG: COMPANY SNAPSHOT
                       TABLE 228 BRAIN BIOTECH AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 229 BRAIN BIOTECH AG: OTHERS
             13.1.2 NOVOZYMES A/S
                       TABLE 230 NOVOZYMES A/S: BUSINESS OVERVIEW
                       FIGURE 64 NOVOZYMES A/S: COMPANY SNAPSHOT
                       TABLE 231 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 232 NOVOZYMES A/S: DEALS
                       TABLE 233 NOVOZYMES A/S: OTHERS
             13.1.3 CODEXIS, INC.
                       TABLE 234 CODEXIS, INC.: BUSINESS OVERVIEW
                       FIGURE 65 CODEXIS, INC.: COMPANY SNAPSHOT
                       TABLE 235 CODEXIS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 236 CODEXIS, INC.: PRODUCT LAUNCHES
                       TABLE 237 CODEXIS, INC.: DEALS
                       TABLE 238 CODEXIS, INC.: OTHERS
             13.1.4 SANOFI
                       TABLE 239 SANOFI: BUSINESS OVERVIEW
                       FIGURE 66 SANOFI: COMPANY SNAPSHOT
                       TABLE 240 SANOFI: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 241 SANOFI: DEALS
             13.1.5 MERCK KGAA
                       TABLE 242 MERCK KGAA: BUSINESS OVERVIEW
                       FIGURE 67 MERCK KGAA: COMPANY SNAPSHOT
                       TABLE 243 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 244 MERCK KGAA: DEALS
                       TABLE 245 MERCK KGAA: OTHERS
             13.1.6 DYADIC INTERNATIONAL INC.
                       TABLE 246 DYADIC INTERNATIONAL INC.: BUSINESS OVERVIEW
                       FIGURE 68 DYADIC INTERNATIONAL INC.: COMPANY SNAPSHOT
                       TABLE 247 DYADIC INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 248 DYADIC INTERNATIONAL INC.: DEALS
             13.1.7 ADVANCED ENZYME TECHNOLOGIES
                       TABLE 249 ADVANCED ENZYME TECHNOLOGIES: BUSINESS OVERVIEW
                       FIGURE 69 ADVANCED ENZYME TECHNOLOGIES: COMPANY SNAPSHOT
                       TABLE 250 ADVANCED ENZYME TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 251 ADVANCED ENZYME TECHNOLOGIES: DEALS
             13.1.8 AMANO ENZYME INC.
                       TABLE 252 AMANO ENZYME INC.: BUSINESS OVERVIEW
                       TABLE 253 AMANO ENZYME INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 254 AMANO ENZYME INC.: DEALS
                       TABLE 255 AMANO ENZYME INC.: OTHERS
             13.1.9 F. HOFFMANN-LA ROCHE LTD.
                       TABLE 256 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                       FIGURE 70 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
                       TABLE 257 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 258 F. HOFFMANN-LA ROCHE LTD.: DEALS
               13.1.10 NEW ENGLAND BIOLABS
                                   TABLE 259 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
                                   TABLE 260 NEW ENGLAND BIOLABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 261 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES
                                   TABLE 262 NEW ENGLAND BIOLABS: DEALS
                                   TABLE 263 NEW ENGLAND BIOLABS: OTHERS
               13.1.11 BBI SOLUTIONS
                                   TABLE 264 BBI SOLUTIONS: BUSINESS OVERVIEW
                                   TABLE 265 BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 266 BBI SOLUTIONS: DEALS
               13.1.12 CREATIVE ENZYMES
                                   TABLE 267 CREATIVE ENZYMES: BUSINESS OVERVIEW
                                   TABLE 268 CREATIVE ENZYMES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
               13.1.13 BIOSEUTICA
                                   TABLE 269 BIOSEUTICA: BUSINESS OVERVIEW
                                   TABLE 270 BIOSEUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 271 BIOSEUTICA: DEALS
               13.1.14 SEKISUI DIAGNOSTICS
                                   TABLE 272 SEKISUI DIAGNOSTICS: BUSINESS OVERVIEW
                                   TABLE 273 SEKISUI DIAGNOSTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 274 SEKISUI DIAGNOSTICS: OTHERS
               13.1.15 ANTOZYME BIOTECH PVT. LTD.
                                   TABLE 275 ANTOZYME BIOTECH PVT. LTD.: BUSINESS OVERVIEW
                                   TABLE 276 ANTOZYME BIOTECH PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
     13.2 OTHER PLAYERS 
             13.2.1 S.I. BIOZYME
                       TABLE 277 S.I. BIOZYME: BUSINESS OVERVIEW
                       TABLE 278 S.I. BIOZYME: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             13.2.2 AUMGENE BIOSCIENCES
                       TABLE 279 AUMGENE BIOSCIENCES: BUSINESS OVERVIEW
                       TABLE 280 AUMGENE BIOSCIENCES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             13.2.3 ENZYME BIOSCIENCE
                       TABLE 281 ENZYME BIOSCIENCE: BUSINESS OVERVIEW
                       TABLE 282 ENZYME BIOSCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             13.2.4 INFINITA BIOTECH PRIVATE LIMITED
                       TABLE 283 INFINITA BIOTECH PRIVATE LIMITED: BUSINESS OVERVIEW
                       TABLE 284 INFINITA BIOTECH PRIVATE LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             13.2.5 BIOLAXI ENZYMES PVT. LTD.
                       TABLE 285 BIOLAXI ENZYMES PVT. LTD.: BUSINESS OVERVIEW
                       TABLE 286 BIOLAXI ENZYMES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             13.2.6 FIDO PHARMA PVT. LTD.
             13.2.7 4BASEBIO
             13.2.8 ANSEL BIOTECH
             13.2.9 GENO TECHNOLOGY INC.
               13.2.10 GUJARAT ENZYME
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 ADJACENT AND RELATED MARKETS (Page No. - 290)
     14.1 INTRODUCTION 
               TABLE 287 MARKETS ADJACENT TO SPECIALTY ENZYMES MARKET
     14.2 LIMITATIONS 
     14.3 INDUSTRIAL ENZYMES MARKET 
             14.3.1 MARKET DEFINITION
             14.3.2 MARKET OVERVIEW
                       TABLE 288 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
                       TABLE 289 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
                       TABLE 290 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2019–2022 (USD MILLION)
                       TABLE 291 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2023–2028 (USD MILLION)
     14.4 FOOD ENZYMES MARKET 
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
             14.4.3 FOOD ENZYMES MARKET, BY APPLICATION
                       TABLE 292 FOOD ENZYMES MARKET, BY TYPE, 2016–2020 (USD MILLION)
                       TABLE 293 FOOD ENZYMES MARKET, BY TYPE, 2021–2026 (USD MILLION)
             14.4.4 FOOD ENZYMES MARKET, BY REGION
                       TABLE 294 FOOD ENZYMES MARKET, BY REGION, 2016–2020 (USD MILLION)
                       TABLE 295 FOOD ENZYMES MARKET, BY REGION, 2021–2026 (USD MILLION)
     14.5 FEED ENZYMES MARKET 
             14.5.1 MARKET DEFINITION
             14.5.2 MARKET OVERVIEW
                       TABLE 296 FEED ENZYMES MARKET, BY REGION, 2016–2019 (USD MILLION)
                       TABLE 297 FEED ENZYMES MARKET, BY REGION, 2020–2025 (USD MILLION)
15 APPENDIX (Page No. - 298)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS